Alpine Biomed eyes global role with Medtronic diagnostics assets
This article was originally published in Clinica
Alpine Biomed is staking out a global leadership position in the specialty diagnostics market after completing the purchase of Medtronic's neurodiagnostic product line for an undisclosed sum on August 1. The Fountain Valley, California company gained all Medtronic neurodiagnostic equipment and accessories, including the Keypoint electromyography (EMG), Clavis hand-held EMG injection device, and needle and surface electrodes. It is Alpine's second deal with Medtronic this year: in May it purchased Medtronic's gastroenterology diagnostic product line, and this latest transaction sees Alpine acquire the whole range of diagnostics tools, ready for integration into its own portfolio for the treatment of various neuropathies.
You may also be interested in...
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.